A patient and public involvement (PPI) review exploring patient reported outcome measures in adult CAR T-cell therapy patients

Summary: Background & Aims: Chimeric Antigen Receptor (CAR) T-cell therapy is a novel anti-cancer treatment option for patients with refractory or relapsed haematological malignancies. Preliminary research shows a significant proportion of patients receiving CAR T-cell therapy develop malnu...

Full description

Bibliographic Details
Main Authors: Nikoletta Mama, Brittany Cucchiaro, Adrian Slee
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Clinical Nutrition Open Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667268523000414